Vynleads, Inc. (VYND)
USD 0.5
(0.0%)
USD 0.5
(0.0%)
| Year | Gross Profit | Gross Profit Growth |
|---|---|---|
| 2023 | -35.57 Thousand USD | -22.03% |
| 2022 | -29.14 Thousand USD | 8.86% |
| 2021 | -31.98 Thousand USD | -278.68% |
| 2020 | -8446.00 USD | -103.88% |
| 2019 | 217.62 Thousand USD | -80.3% |
| 2018 | 1.1 Million USD | -32.61% |
| 2017 | 1.63 Million USD | 0.0% |
| Year | Gross Profit | Gross Profit Growth |
|---|---|---|
| 2024 Q2 | -4636.00 USD | -9.47% |
| 2024 Q1 | -4235.00 USD | 67.56% |
| 2023 Q1 | -12.92 Thousand USD | -19.28% |
| 2023 FY | -35.57 Thousand USD | -22.03% |
| 2023 Q4 | -13.05 Thousand USD | -52.54% |
| 2023 Q3 | -8558.00 USD | -726.06% |
| 2023 Q2 | -1036.00 USD | 91.98% |
| 2022 Q3 | -4873.00 USD | 19.67% |
| 2022 Q2 | -6066.00 USD | 17.22% |
| 2022 Q1 | -7328.00 USD | 0.74% |
| 2022 FY | -29.14 Thousand USD | 8.86% |
| 2022 Q4 | -10.83 Thousand USD | -122.31% |
| 2021 FY | -31.98 Thousand USD | -278.68% |
| 2021 Q2 | -7745.00 USD | 4.83% |
| 2021 Q3 | -338.00 USD | 95.64% |
| 2021 Q4 | -7383.00 USD | -2084.32% |
| 2021 Q1 | -8138.00 USD | -164.91% |
| 2020 Q4 | -3072.00 USD | 34.98% |
| 2020 Q2 | -5663.00 USD | -212.94% |
| 2020 Q1 | 5014.00 USD | 0.14% |
| 2020 Q3 | -4725.00 USD | 16.56% |
| 2020 FY | -8446.00 USD | -103.88% |
| 2019 FY | 217.62 Thousand USD | -80.3% |
| 2019 Q4 | 5007.00 USD | -94.38% |
| 2019 Q3 | 89.04 Thousand USD | 64.77% |
| 2019 Q2 | 54.03 Thousand USD | -22.29% |
| 2019 Q1 | 69.54 Thousand USD | -64.87% |
| 2018 Q2 | 157.72 Thousand USD | -76.37% |
| 2018 Q3 | 81.61 Thousand USD | -48.26% |
| 2018 Q4 | 197.93 Thousand USD | 142.52% |
| 2018 FY | 1.1 Million USD | -32.61% |
| 2018 Q1 | 667.37 Thousand USD | 0.0% |
| 2017 FY | 1.63 Million USD | 0.0% |
| Name | Gross Profit | Gross Profit Difference |
|---|---|---|
| Achiko AG | 23.34 Thousand USD | 252.367% |
| Accelera Innovations, Inc | - USD | Infinity% |
| Aspyra Inc. | 3.91 Million USD | 100.908% |
| Cannabis Sativa, Inc. | 773.08 Thousand USD | 104.601% |
| CompuMed, Inc. | 2.88 Million USD | 101.232% |
| CompuGroup Medical SE & Co. KGaA | 413.14 Million USD | 100.009% |
| Cogstate Limited | 24.7 Million USD | 100.144% |
| CareView Communications, Inc. | 6.53 Million USD | 100.545% |
| Craneware plc | 162.19 Million USD | 100.022% |
| Caduceus Software Systems Corp. | 925.07 Thousand USD | 103.845% |
| Certive Solutions Inc. | 137.87 Thousand USD | 125.799% |
| Drug Free Solution, Inc. | 805.00 USD | 4518.634% |
| DATATRAK International, Inc. | 5.14 Million USD | 100.691% |
| Strainsforpains, Inc. | 84.11 Thousand USD | 142.287% |
| Healixa Inc. | 210.81 Thousand USD | 116.873% |
| Easy Technologies Inc. | - USD | Infinity% |
| eWellness Healthcare Corporation | - USD | Infinity% |
| Founders Bay Holdings | 12.3 Million USD | 100.289% |
| Health Discovery Corporation | - USD | Infinity% |
| Healthcare Integrated Technologies, Inc. | 82.05 Thousand USD | 143.351% |
| H-Source Holdings Ltd. | - USD | Infinity% |
| InterCare DX, Inc. | -298.05 USD | -11834.239% |
| IQ-AI Limited | 614.03 Thousand USD | 105.793% |
| Cannabiz Mobile, Inc. | - USD | Infinity% |
| Mednow Inc. | -858.82 Thousand USD | 95.858% |
| Galileo Life Sciences, Inc. | - USD | Infinity% |
| MediXall Group, Inc. | -3.13 Million USD | 98.867% |
| Mitesco, Inc. | - USD | Infinity% |
| MobileSmith, Inc. | 821.2 Thousand USD | 104.331% |
| NantHealth, Inc. | 38.16 Million USD | 100.093% |
| Net Medical Xpress Solutions, Inc. | -60 Thousand USD | 40.717% |
| OneLife Technologies Corp. | - USD | Infinity% |
| ORHub, Inc. | 222.9 Thousand USD | 115.958% |
| Patient Access Solutions, Inc. | 212.73 Thousand USD | 116.72% |
| Pharma-Bio Serv, Inc. | 5.06 Million USD | 100.702% |
| PPJ Healthcare Enterprises, Inc. | 216.06 Thousand USD | 116.463% |
| Medical Cannabis Payment Solutions, Inc. | -21.91 Thousand USD | -62.294% |
| Renalytix Plc | 156 Thousand USD | 122.801% |
| Revium Recovery Inc. | -2000.00 USD | -1678.5% |
| RYAH Group, Inc. | - USD | Infinity% |
| Carepay Inc. | 396.65 Thousand USD | 108.968% |
| Vaso Corporation | 50.59 Million USD | 100.07% |